Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making
Open Access
- 3 March 2024
- journal article
- review article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 55 (4) , 421-438
Abstract
Background: Chronic kidney disease (CKD) presents a persistent global health challenge, characterized by complex pathophysiology and diverse progression patterns. Metabolomics has emerged as a valuable tool in unraveling the intricate molecular mechanisms driving CKD progression. Summary: This comprehensive review provides a summary of recent progress in the field of metabolomics in kidney disease with a focus on spatial metabolomics to shed important insights to enhancing our understanding of CKD progression, emphasizing its transformative potential in early disease detection, refined risk assessment, and the development of targeted interventions to improve patient outcomes. Key Message: Through an extensive analysis of metabolic pathways and small-molecule fluctuations, bulk and spatial metabolomics offers unique insights spanning the entire spectrum of CKD, from early stages to advanced disease states. Recent advances in metabolomics technology have enabled spatial identification of biomarkers to provide breakthrough discoveries in predicting CKD trajectory and enabling personalized risk assessment. Furthermore, metabolomics can help decipher the complex molecular intricacies associated with kidney diseases for exciting novel therapeutic approaches. A recent example is the identification of adenine as a key marker of kidney fibrosis for diabetic kidney disease using both untargeted and targeted bulk and spatial metabolomics. The metabolomics studies were critical to identify a new biomarker for kidney failure and to guide new therapeutics for diabetic kidney disease. Similar approaches are being pursued for acute kidney injury and other kidney diseases to enhance precision medicine decision-making.Keywords
This publication has 107 references indexed in Scilit:
- Evaluation of amino acids and other related metabolites levels in end-stage renal disease (ESRD) patients on hemodialysis by LC/MS/MS and GC/MSAnalytical and Bioanalytical Chemistry, 2023
- Urinary metabolomics to develop predictors for pediatric acute kidney injuryPediatric Nephrology, 2022
- Discovery of potential biomarkers in acute kidney injury by ultra-high-performance liquid chromatography-tandem quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF–MS)International Urology and Nephrology, 2021
- Association of the Estimated Glomerular Filtration Rate With vs Without a Coefficient for Race With Time to Eligibility for Kidney TransplantJAMA Network Open, 2021
- Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucoseDiabetologia, 2018
- Metabolomics as a Tool to Understand Pathophysiological Processes2018
- LC-QTOF-MS-based targeted metabolomics of arginine-creatine metabolic pathway-related compounds in plasma: application to identify potential biomarkers in pediatric chronic kidney diseaseAnalytical and Bioanalytical Chemistry, 2015
- Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathyAnalytical and Bioanalytical Chemistry, 2012
- A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitusDiabetologia, 2011
- Comparing and combining NMR spectroscopy and mass spectrometry in metabolomicsAnalytical and Bioanalytical Chemistry, 2006